相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells
May Daher et al.
BLOOD (2021)
Chimeric antigen receptor (CAR) natural killer (NK)-cell therapy: leveraging the power of innate immunity
Hind Rafei et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysis
Sarah Nersesian et al.
TRANSLATIONAL ONCOLOGY (2021)
GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells
Enli Liu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response
Elisa C. Toffoli et al.
CANCERS (2021)
Optimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy
Adrian Fernandez et al.
CANCERS (2021)
Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells
Maxwell Y. Lee et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Cancer stem cells: A review from origin to therapeutic implications
Mohammad Reza Atashzar et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
CAR-NK for tumor immunotherapy: Clinical transformation and future prospects
Wenxiu Wang et al.
CANCER LETTERS (2020)
Use of chimeric antigen receptor NK-92 cells to target mesothelin in ovarian cancer
Bihui Cao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Sarwish Rafiq et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells
Jason B. Williams et al.
NATURE COMMUNICATIONS (2020)
CXCR1 Expression to Improve Anti-Cancer Efficacy of Intravenously Injected CAR-NK Cells in Mice with Peritoneal Xenografts
Yu Yang Ng et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs)
Julia Hambach et al.
CELLS (2020)
Tissue factor as a new target for CAR-NK cell immunotherapy of triple-negative breast cancer
Zhiwei Hu
SCIENTIFIC REPORTS (2020)
Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D
Ece Canan Sayitoglu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Inhibition of MICA and MICB Shedding Elicits NK-Cell-Mediated Immunity against Tumors Resistant to Cytotoxic T Cells
Lucas Ferrari de Andrade et al.
CANCER IMMUNOLOGY RESEARCH (2020)
NKG2D Ligand Shedding in Response to Stress: Role of ADAM10
Alessandra Zingoni et al.
FRONTIERS IN IMMUNOLOGY (2020)
Overcoming Heterogeneity of Antigen Expression for Effective CAR T Cell Targeting of Cancers
Sareetha Kailayangiri et al.
CANCERS (2020)
CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas
Margery Gang et al.
BLOOD (2020)
CAR-T design: Elements and their synergistic function
Jayapriya Jayaraman et al.
EBIOMEDICINE (2020)
Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics
Emily Y. Yang et al.
FRONTIERS IN ONCOLOGY (2020)
Human NK-92 Cells Function as Target Cells for Human NK Cells - Implications for CAR NK-92 Therapies
Hans Bergman et al.
ANTICANCER RESEARCH (2020)
A novel chimeric PD1-NKG2D-41BB receptor enhances antitumor activity of NK92 cells against human lung cancer H1299 cells by triggering pyroptosis
Chengui Lu et al.
MOLECULAR IMMUNOLOGY (2020)
Rationally designed redirection of natural killer cells anchoring a cytotoxic ligand for pancreatic cancer treatment
Young Eun Lee et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways
Yan Yang et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?
Bolun Jiang et al.
FRONTIERS IN ONCOLOGY (2020)
Next-generation cell therapies: the emerging role of CAR-NK cells
Rafet Basar et al.
BLOOD ADVANCES (2020)
Robo1-specific chimeric antigen receptor natural killer cell therapy for pancreatic ductal adenocarcinoma with liver metastasis
Chaojie Li et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2020)
shp-2 gene knockout upregulates CAR-driven cytotoxicity of YT NK cells
V. G. Subrakova et al.
VAVILOVSKII ZHURNAL GENETIKI I SELEKTSII (2020)
Characterization of a Novel Third-Generation Anti-CD24-CAR against Ovarian Cancer
Ruediger Klapdor et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
Kevin C. Conlon et al.
CLINICAL CANCER RESEARCH (2019)
2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies
Yingxi Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Anti-αFR CAR-engineered NK-92 Cells Display Potent Cytotoxicity Against αFR-positive Ovarian Cancer
Xiang Ao et al.
JOURNAL OF IMMUNOTHERAPY (2019)
Development of c-MET-specific chimeric antigen receptor-engineered natural killer cells with cytotoxic effects on human liver cancer HepG2 cells
Bing Liu et al.
MOLECULAR MEDICINE REPORTS (2019)
Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression
Antonino Bruno et al.
FRONTIERS IN IMMUNOLOGY (2019)
IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells
Yeon Ho Choi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Robo1-specific CAR-NK Immunotherapy Enhances Efficacy of 125I Seed Brachytherapy in an Orthotopic Mouse Model of Human Pancreatic Carcinoma
Ning Xia et al.
ANTICANCER RESEARCH (2019)
Impairment of NKG2D-Mediated Tumor Immunity by TGF-β
Mariya Lazarova et al.
FRONTIERS IN IMMUNOLOGY (2019)
NK Cell-Based Immunotherapy for Hematological Malignancies
Simona Sivori et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Targeting T cell malignancies using CAR-based immunotherapy: challenges and potential solutions
Lauren C. Fleischer et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Adoptive cellular therapies: the current landscape
Maartje W. Rohaan et al.
VIRCHOWS ARCHIV (2019)
An Antibody Designed to Improve Adoptive NK-Cell Therapy Inhibits Pancreatic Cancer Progression in a Murine Model
Jaemin Lee et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Therapeutic Potential of Natural Killer Cells in Gastric Cancer
Yu Du et al.
FRONTIERS IN IMMUNOLOGY (2019)
Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells
L. Herrera et al.
SCIENTIFIC REPORTS (2019)
The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation
Annekathrin Heinze et al.
FRONTIERS IN IMMUNOLOGY (2019)
NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives
Cristiana Lo Nigro et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
E. Liu et al.
LEUKEMIA (2018)
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li et al.
CELL STEM CELL (2018)
Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels
Lijun Xu et al.
MOLECULAR ONCOLOGY (2018)
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
Qing Zhang et al.
NATURE IMMUNOLOGY (2018)
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity
Lucas Ferrari de Andrade et al.
SCIENCE (2018)
Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37
Dhifaf Sarhan et al.
CANCER IMMUNOLOGY RESEARCH (2018)
The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma
Bianca Simon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Lack of FcRn Impairs Natural Killer Cell Development and Functions in the Tumor Microenvironment
Diana Cadena Castaneda et al.
FRONTIERS IN IMMUNOLOGY (2018)
Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
Qing Zhang et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
KIR downregulation by IL-12/15/18 unleashes human NK cells from KIR/HLA-I inhibition and enhances killing of tumor cells
Eva-Maria Ewen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect
Martin Felices et al.
JCI INSIGHT (2018)
Liver-infiltrating CD11b(-)CD27(-) NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression
Qiong-Fang Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy
Jesus I. Luna et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor
K. H. Chen et al.
LEUKEMIA (2017)
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Donald M. O'Rourke et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
Yago Pico de Coana et al.
ONCOTARGET (2017)
Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma
Qing Zhang et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
Developmental and Functional Control of Natural Killer Cells by Cytokines
Yang Wu et al.
FRONTIERS IN IMMUNOLOGY (2017)
Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications
Anushruti Sarvaria et al.
FRONTIERS IN IMMUNOLOGY (2017)
The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3
Lulu Ni et al.
SCIENTIFIC REPORTS (2017)
Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma
Eric S. Yvon et al.
CYTOTHERAPY (2017)
Markers and Function of Human NK Cells in Normal and Pathological Conditions
Genny Del Zotto et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2017)
Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer
David L. Hermanson et al.
STEM CELLS (2016)
Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival
Sabrina Genssler et al.
ONCOIMMUNOLOGY (2016)
Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells
Dhifaf Sarhan et al.
CANCER RESEARCH (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
Christine E. Brown et al.
CLINICAL CANCER RESEARCH (2015)
Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function
Heinrich Schlums et al.
IMMUNITY (2015)
Epigenetic Modification and Antibody-Dependent Expansion of Memory-like NK Cells in Human Cytomegalovirus-Infected Individuals
Jaewon Lee et al.
IMMUNITY (2015)
NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype
Erik Ames et al.
JOURNAL OF IMMUNOLOGY (2015)
DAP12-Based Activating Chimeric Antigen Receptor for NK Cell Tumor Immunotherapy
Katrin Toepfer et al.
JOURNAL OF IMMUNOLOGY (2015)
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
Nadja Müller et al.
JOURNAL OF IMMUNOTHERAPY (2015)
NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma
Cinzia Fionda et al.
BIOMED RESEARCH INTERNATIONAL (2015)
CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells
Jianfeng Han et al.
SCIENTIFIC REPORTS (2015)
Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor
Kurt Schönfeld et al.
MOLECULAR THERAPY (2014)
Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein
Veronika Bachanova et al.
BLOOD (2014)
Current concepts in the diagnosis and management of cytokine release syndrome
Daniel W. Lee et al.
BLOOD (2014)
MicroRNA-218 inhibits cell invasion and migration of pancreatic cancer via regulating ROBO1
Hang He et al.
CANCER BIOLOGY & THERAPY (2014)
Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
Darya Alizadeh et al.
CANCER RESEARCH (2014)
Development of NK cell expansion methods using feeder cells from human myelogenous leukemia cell line
Duk Seong Bae et al.
BLOOD RESEARCH (2014)
A Chimeric Receptor with NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor Cells
Yu-Hsiang Chang et al.
CANCER RESEARCH (2013)
Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXRγ activation
Wai-Hang Leung et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Inhibition of Glycogen Synthase Kinase-3 Increases NKG2D Ligand MICA Expression and Sensitivity to NK Cell-Mediated Cytotoxicity in Multiple Myeloma Cells: Role of STAT3
Cinzia Fionda et al.
JOURNAL OF IMMUNOLOGY (2013)
Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
David A. Knorr et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Cytokine activation induces human memory-like NK cells
Rizwan Romee et al.
BLOOD (2012)
Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor
Christiane Sahm et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation
Martha Luevano et al.
HUMAN IMMUNOLOGY (2012)
Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors
Jing Ni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen
Bree Foley et al.
JOURNAL OF IMMUNOLOGY (2012)
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
Melissa A. Geller et al.
CYTOTHERAPY (2011)
Tumor Evasion from T Cell Surveillance
Katrin Toepfer et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Modulation of NKG2D-ligand Cell Surface Expression Enhances Immune Cell Therapy of Cancer
Baocheng Huang et al.
JOURNAL OF IMMUNOTHERAPY (2011)
5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
Julie Vincent et al.
CANCER RESEARCH (2010)
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
Jennifer S. Ko et al.
CLINICAL CANCER RESEARCH (2009)
DAP10-and DAP12-associated receptors in innate immunity
Lewis L. Lanier
IMMUNOLOGICAL REVIEWS (2009)
CD56bright natural killer (NK) cells: an important NK cell subset
Aurelie Poli et al.
IMMUNOLOGY (2009)
Natural killer cell cytotoxicity: how do they pull the trigger?
Nicola J. Topham et al.
IMMUNOLOGY (2009)
Permanent silencing of NKG2A expression for cell-based therapeutics
Constanca Figueiredo et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas
Anna Kruschinski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells
C Imai et al.
BLOOD (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway
DD Billadeau et al.
NATURE IMMUNOLOGY (2003)
Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy
TA Fehniger et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
